Consun Pharmaceutical Group Ltd
Consun Pharmaceutical Group's GHG Emissions Data Preview
In 2023, Consun Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Consun Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Consun Pharmaceutical Group's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Consun Pharmaceutical Group amounted to 79,125.22 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Consun Pharmaceutical Group increased by 9.81%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Consun Pharmaceutical Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Consun Pharmaceutical Group's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Consun Pharmaceutical Group were 54,210.46 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Consun Pharmaceutical Group reduced its Scope 1 emissions over time?
Since 2020, Consun Pharmaceutical Group's Scope 1 emissions have increased by 230.17%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Consun Pharmaceutical Group's Scope 1 emissions increased by 1.87%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Consun Pharmaceutical Group's Scope 2 emissions?
In 2023, Consun Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 24,914.76 tCOâ‚‚e without specifying the calculation method.
Has Consun Pharmaceutical Group reduced its Scope 2 emissions over time?
Since 2020, Consun Pharmaceutical Group's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 61.38%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Consun Pharmaceutical Group's Scope 2 emissions (Unspecified Calculation Method) rose by 32.23% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does Consun Pharmaceutical Group use for Scope 2 reporting?
In 2023, Consun Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology.
Consun Pharmaceutical Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)